Your session is about to expire
← Back to Search
CMV Vaccine for Bone Marrow Transplant Recipients
Study Summary
This trial is testing a CMV vaccine in children undergoing stem cell transplants to see if it is safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 6104 Patients • NCT01346592Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What findings have been reported regarding the efficacy of Multi-peptide CMV-Modified Vaccinia Ankara Vaccine?
"Currently, 16 clinical trials are underway to evaluate the efficacy of Multi-peptide CMV-Modified Vaccinia Ankara Vaccine; 0 of them have entered Phase 3. The majority of those studies take place in Boston, MA, but 75 other locations across the US and abroad have active investigation sites for this vaccine."
Is it possible for me to join this experiment?
"This clinical trial requires 80 child participants aged between 1 and 21 who have undergone hematopoietic cell transplantation. In order to be eligible, the participants must conform to a set of criteria: they should demonstrate willingness to comply with study/follow-up procedures for one year post HCT; females of potential-childbearing age, as well as sexually active males, need to use an effective contraceptive (hormonal or barrier method) from pre-study entry till 90 days after HCT; in case there is suspicion of pregnancy during the course of the trial, the treating physician ought to be informed immediately; conditioned and immunos"
Are individuals over the age of 85 excluded from this investigation?
"To be permitted to join this trial, patients must fall between one year and twenty-one years in age. This clinical study has 26 spots available for younger participants and 51 positions open to those over 65."
To what extent is the participant pool growing for this analysis?
"Affirmative, the information hosted on clinicaltrials.gov confirms that this medical experiment is currently recruiting patients. It was first posted on May 11th 2018 and last updated on June 14th 2022. The trial necessitates 80 people from a single location to participate in it."
Is this investigation presently open to new participants?
"Affirmative. According to clinicaltrials.gov, this study is actively recruiting participants with the listing first published on May 11th 2018 and last updated June 14th 2022. Eighty candidates must be sourced from one medical centre."
Share this study with friends
Copy Link
Messenger